August 28, 2013
The Tokushukai Group, which runs private hospitals and clinics across Japan, has decided to stop using Novartis Pharma’s angiotensin receptor blocker (ARB) Diovan (valsartan) and two other drugs containing valsartan. The group will stop its use of Diovan products, considering...read more